Search Results

Search Results for "diabetes"

• Long-term health questions for Lipitor
  A story in Men’s Journal explores the question of how people who use statins such as Lipitor should react to a recent study indicating that the cholesterol-lowering drugs may counteract the benefits of exercise. The study in the Journal of the American College of Cardiology looked at a group of ov...

• Benicar maker dealing with challenges
  The Wall Street Journal reports that Daiichi Sankyo Co., Japan’s third-largest pharmaceutical manufacturer, is hoping sales of new drugs will help the company offset lost revenue from patent expirations. Although Daiichi Sankyo returned to profit in the fiscal fourth quarter and posted a six-fold ...

• More states pursuing legal action against drug companies
  The Wall Street Journal reports on increasingly aggressive efforts by attorneys general in several U.S. states to pursue legal actions against drug companies for deceptive marketing. Using consumer protection laws as a basis, state officials have gone after some major pharmaceutical companies, inclu...

• Statins may cancel out exercise benefits
  A new study suggests that cholesterol-lowering drugs called statins, such as Pfizer’s Lipitor, may negate some of the fitness benefits of exercise. A story in the New York Times says the study’s findings may present a tricky quandary where preventive health care is concerned. While statins are r...

• Byetta/Januvia Pancreatic Cancer Lawsuit
  Diabetes cases are skyrocketing, with the U.S. Centers for Disease Control and Prevention estimating that the number of Americans who have the condition may climb from its current rate of 1-in-10 to 1-in-5, or even 1-in-3 by mid-century. But beyond the inherent health risks of diabetes, some medicat...

• Researchers find possible explanation for memory loss linked with drugs
  Researchers at the University of Arizona have announced a discovery that may eventually help explain the memory loss associated with Lipitor and other drugs in the popular class of cholesterol-lowering drugs called statins. A news release from the university notes that physicians and the U.S. Food a...

• Statin risks may outweigh benefits for older patients
  A clinical study has Australian researchers questioning whether the risks of anti-cholesterol drugs called statins may outweigh the benefits for older patients, according to a report in The Conversation. According to the report, common side effects from statins such as Lipitor include abdominal pain...

• Statins may cause risk of muscular injury
  A new study has concluded that the class of cholesterol-lowering medications known as statins, which include Lipitor, may put users at greater risk of muscular injury. A story in The Telegraph quotes researcher Dr. Ishak Mansi of the North Texas Health Care System in Dallas as saying: “Musculo...

• Investors cautioned against Merck
  An item on investing blog Seeking Alpha advises readers not to own stock in the pharmaceutical company Merck, in part because of safety risks associated with its products. The item mentions a recent study published in the medical journal JAMA Internal Medicine. Researchers concluded that a type of d...

• Doctor: Januvia and Byetta problems part of pattern
  In a recent issue of the journal Diabetes Care, Peter Butler, MD, of the University of California Los Angeles weighs in on recent research showing a potential link between certain diabetes drugs and an inflammation of the cancer called pancreatitis, as well as pancreatic cancer. Butler himself was l...